HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR To Consider EWG Recommendations For 2005 Ingredient Priorities

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel will consider raising the priority level of a number of cosmetic ingredients in 2005 in response to concerns expressed by the Environmental Working Group

You may also be interested in...



CFSAN 2005 Priorities Include Responding To EWG Petition

Responding to a citizen petition from the Environmental Working Group requesting FDA halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics is an "A" list priority for the agency's Center for Food Safety & Applied Nutrition in fiscal 2005

CFSAN 2005 Priorities Include Responding To EWG Petition

Responding to a citizen petition from the Environmental Working Group requesting FDA halt the unlawful distribution of misbranded, adulterated and unlabeled cosmetics is an "A" list priority for the agency's Center for Food Safety & Applied Nutrition in fiscal 2005

CTFA Urges Firms To Submit Ingredient Safety Data Promptly To CIR

Companies using ingredients in cosmetics and personal care products found to have insufficient data to determine their safety by the Cosmetic Ingredient Review Expert Panel should submit data on those ingredients to the panel as soon as possible, Cosmetic, Toiletry and Fragrance Association President Ed Kavanaugh advised

Related Content

UsernamePublicRestriction

Register

RS012259

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel